# Older Adults Turn to Cannabis Primarily for Symptom Management – Neurology Advisor > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management-neurology-advisor/ > **Published:** 2026-05-18T20:25:42-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:54:54-04:00 > **Clinical Summary:** Why older adults use cannabis for symptom management and how clinicians should assess efficacy, safety, and drug interactions in this population. --- ✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepPainAnxietyNeurologyResearchAgingSafety Why This Matters Clinicians treating older adults should understand that cannabis use in this population is primarily motivated by symptom management rather than recreational purposes, which may warrant reassessment of pain, sleep, and [anxiety management](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/) strategies in their clinical approach. This evidence supports the need for open, non-judgmental conversations with older patients about cannabis use, as it may indicate inadequately treated symptoms that could benefit from conventional or complementary interventions. Understanding these motivations helps clinicians provide more comprehensive care while monitoring for drug interactions and safety concerns specific to aging populations. Clinical Summary # Clinical Summary This report documents that older adults are increasingly using cannabis primarily for symptom management rather than recreational purposes, with perceived efficacy being a key driver of use in this population. The finding is clinically significant because older adults often experience multiple chronic conditions such as [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), insomnia, and chemotherapy-related side effects where cannabis may offer symptom relief, yet evidence-based guidance for this age group remains limited. Understanding the symptom profiles and perceived benefits driving cannabis use in older patients can help clinicians engage in more informed discussions about alternative and complementary therapies during patient encounters. The shift toward symptom-focused use in geriatric populations underscores the need for additional research specifically in older adults to establish safety profiles, efficacy data, and appropriate dosing recommendations that account for age-related pharmacokinetic changes and polypharmacy concerns. Clinicians should document cannabis use as part of their medication history with older patients and consider having evidence-informed conversations about realistic expectations, potential drug interactions, and when cannabis might be appropriate relative to conventional treatments for their specific conditions. Dr. Caplan’s Take “What I’m seeing in my practice aligns with this data: older patients are turning to cannabis not for recreational purposes but as a pragmatic tool for conditions like neuropathic pain, insomnia, and chemotherapy-related nausea where conventional options have failed or created intolerable side effects. The challenge is that we’re operating with a significant evidence gap, so I counsel patients carefully about dose, drug interactions, and fall risk while being honest that for some conditions, the clinical benefit they’re experiencing is real and measurable.” Clinical Perspective While the growing use of cannabis among older adults for symptom management reflects both patient-driven interest and potential treatment gaps, clinicians should recognize that evidence for efficacy in this population remains limited and heterogeneous across different conditions and cannabinoid formulations. Older adults may be particularly vulnerable to drug interactions, cognitive effects, and fall risk from cannabis, yet they are often underrepresented in [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) and may lack access to quality medical guidance about use. The self-reported perception of effectiveness does not necessarily align with rigorous efficacy data, and selection of cannabinoid type, dose, and route of administration is frequently made without standardized clinical protocols. As cannabis becomes more accessible, primary care and specialty providers should develop competency in discussing cannabis use with older patients, including explicit inquiry about current or contemplated use, while educating patients about gaps in evidence and potential harms specific to aging. Until more robust [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) emerges in older populations, a 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/sleep/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Older%20Adults%20Turn%20to%20Cannabis%20Primarily%20for%20Symptom%20Management%20-%20Neurology%20Advisor%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55416)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55416)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Older%20Adults%20Turn%20to%20Cannabis%20Primarily%20for%20Symptom%20Management%20-%20Neurology%20Advisor%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55416)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Older Adults Turn to Cannabis Primarily for Symptom Management – MPR – eMPR.com](https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management-mpr-empr-com/) - [Society – Cannabis use among older adults is rising rapidly—especially for chronic pain …](https://cedclinic.com/cannabis-use-drug-interactions-older-adults/) - [Cannabis edibles in dementia care: What families should know – AZ Family](https://cedclinic.com/cannabis-use-in-dementia-care-families-know/) 📰 Source: [https://www.neurologyadvisor.com/news/older-adults-turn-to-cannabis-primarily-for-symptom-management/](https://www.neurologyadvisor.com/news/older-adults-turn-to-cannabis-primarily-for-symptom-management/) Further Reading Cannabis Policy Wire[Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I](https://cedclinic.com/mdmb-4en-pinaca-schedule-i-placement/) CED Clinic Blog[Fear of recurrence, secondary cancers, and health problems in long-term survivors of childhood cancer: Findings from a Canadian cohort.](https://cedclinic.com/fear-of-recurrence-secondary-cancers-and-health-problems-in-long-term-survi/) CED Clinic Blog[Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical cannabis patients across 45 days.](https://cedclinic.com/associations-of-cannabis-use-other-substances-and-lifestyle-choices-on-anxi/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).